135 related articles for article (PubMed ID: 8787036)
1. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
Aymard N; Viala A; Stein I; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
3. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM
Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
Chang WH; Lin SK; Jann MW; Lam YW; Chen TY; Chen CT; Hu WH; Yeh EK
Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942
[TBL] [Abstract][Full Text] [Related]
5. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population.
Shibasaki M; Someya T; Takahashi S
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218
[TBL] [Abstract][Full Text] [Related]
6. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study.
Chang WH; Lin SK; Jann MW
J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148
[TBL] [Abstract][Full Text] [Related]
7. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?
Chang WH
Psychopharmacology (Berl); 1992; 106(3):289-96. PubMed ID: 1570373
[TBL] [Abstract][Full Text] [Related]
8. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population.
Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685
[TBL] [Abstract][Full Text] [Related]
9. Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex.
Chang WH; Wu HS; Tseng YT
Biol Psychiatry; 1987 Nov; 22(11):1369-74. PubMed ID: 3663789
[TBL] [Abstract][Full Text] [Related]
10. Plasma homovanillic acid levels and subtyping of schizophrenia.
Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK
Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
Someya T; Shibasaki M; Noguchi T; Takahashi S; Inaba T
J Clin Psychopharmacol; 1992 Jun; 12(3):169-74. PubMed ID: 1629382
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations.
Aymard N; Viala A; Clement MN; Jacquot M; Vacheron MN; Gauillard J; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):975-88. PubMed ID: 12369274
[TBL] [Abstract][Full Text] [Related]
13. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
Wistedt B; Koskinen T; Thelander S; Nerdrum T; Pedersen V; Mølbjerg C
Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs.
Chang WH; Jaw SS; Wu HS; Tsay L; Yeh EK
Psychopharmacology (Berl); 1988; 96(3):285-8. PubMed ID: 3146762
[TBL] [Abstract][Full Text] [Related]
15. Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.
Someya T; Takahashi S; Shibasaki M; Inaba T; Cheung SW; Tang SW
Psychiatry Res; 1990 Feb; 31(2):111-20. PubMed ID: 2326392
[TBL] [Abstract][Full Text] [Related]
16. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol reductase activity in red blood cells from oriental patients on haloperidol.
Someya T; Shibasaki M; Kato T; Noguchi T; Ishida N; Takahashi S
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):275-8. PubMed ID: 1871328
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients.
Chang WH; Hwu HG; Lane HY; Lin SK; Chen TY; Chen H; Wei HL; Lin WL; Lin HN
Psychiatry Res; 1991 Sep; 38(3):215-25. PubMed ID: 1754634
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R
Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340
[TBL] [Abstract][Full Text] [Related]
20. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
Viala A; Aymard N; Leyris A; Caroli F
Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
